- 2025-04-12 17:33LCMV gp33-41 TFA
- 2025-04-12 17:33(-)-Bornyl acetate ((-)-bornyl acetate; L-(-)-Bornyl acetate) 5655-61-8
- 2025-04-12 17:33(Aminooxy)acetamide-Val-Cit-PAB-MMAE 2446645-88-9
- 2025-04-12 17:33NMS-0963 2765304-82-1
- 2025-04-12 17:33(-)-5′-Noraristeromycin 150132-22-2
- 2025-04-12 17:33ASN03576800 957513-35-8
- 2025-04-12 17:33(Z)-LFM-A13 244240-24-2
- 2025-04-12 17:33ALK-IN-21 2901889-01-6
- 2025-04-12 17:33Antiviral agent 23 35940-03-5
- 2025-04-12 17:33ADC Control Human IgG1-SN-38
- 2025-04-12 17:33PD173955 260415-63-2
- 2025-04-12 17:33ALKBH1-IN-3
- 2025-04-12 17:33Briobacept (BR 3FC) 869881-54-9
- 2025-04-12 17:3313(S)-HPODE 33964-75-9
- 2025-04-12 17:33(Z)-Orantinib ((Z)-SU6668) 210644-62-5
- 2025-04-12 17:3317-AEP-GA 75747-23-8
- 2025-04-12 17:33PT2399 1672662-14-4
- 2025-04-12 17:33GANT58 (NSC 75503) 64048-12-0
- 2025-04-12 17:33Cabenoside D 88901-40-0
- 2025-04-12 17:33FAK inhibitor 7 2890814-94-3
